Cart
sales@molnova.com
KT-362 fumarate
CAS No. 105394-80-7
KT-362 fumarate( —— )
Catalog No. M34305 CAS No. 105394-80-7
KT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 491 | Get Quote |
|
| 5MG | 710 | Get Quote |
|
| 10MG | 998 | Get Quote |
|
| 25MG | 1435 | Get Quote |
|
| 50MG | 1914 | Get Quote |
|
| 100MG | 2547 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKT-362 fumarate
-
NoteResearch use only, not for human use.
-
Brief DescriptionKT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.
-
DescriptionKT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.KT-362 fumarate causes vasodilation by affecting intracellular calcium mobilization in atrial muscle cells.KT-362 fumarate has a relaxing effect on femoral and basilar artery strips in rabbits.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel | Potassium Channel | Sodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105394-80-7
-
Formula Weight516.61
-
Molecular FormulaC26H32N2O7S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C/C(O)=O)\C(O)=O.C(CCNCCC1=CC(OC)=C(OC)C=C1)(=O)N2C=3C(=CC=CC3)SCCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Efonidipine
Efonidipine (NZ-105) is a potent, dual T-type and L-type calcium channel blocker.
-
TPC2-A1-P
TPC2-A1-P is a membrane-permeable two-pore channel 2 (TPC2) agonist that differentially activates two-pore channel 2 (TPC2) and mimics the activation of TPC2 with NAADP and PIP(2). TPC2-A1-P can be used to study neurodegenerative lysosomal storage diseases.
-
ACT 709478
ACT 709478 is a potent, selective, orally-bioavailable, brain penetrant T-type calcium channel blocker with IC50 of 6.4, 18, and 7.5 nM for Cav3.1, Cav3.2, and Cav3.3 channels respectively.
